Skip to main content
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1999 Sep;90(9):987–992. doi: 10.1111/j.1349-7006.1999.tb00846.x

Receptor for Hyaluronan‐mediated Motility and CD44 Expressions in Colon Cancer Assessed by Quantitative Analysis Using Real‐time Reverse Transcriptase‐Polymerase Chain Reaction

Yoichi Yamada 1,2,, Naoki Itano 1, Hisashi Narimatsu 3, Takashi Kudo 3, Setsuo Hirohashi 4, Atsushi Ochiai 4, Atsushi Niimi 2, Minoru Ueda 2, Koji Kimata 1,
PMCID: PMC5926169  PMID: 10551329

Abstract

Receptor for hyaluronan (HA)‐mediated motility (RHAMM) is a receptor for HA‐mediated motility and its expression is correlated with malignancy of ras‐transformed cells in that binding of HA to this receptor activates their migratory ability. CD44, a cell surface receptor for HA is also implicated in metastatic behavior of some cancer cells. In this study we examined the relationships of cancer progression with mRNA levels of RHAMM, CD44 (all forms), and exon 6 of CD44 using the real‐time reverse transcriptase‐polymerase chain reaction method in specimens of colon cancers at different diagnostic stages from 30 patients. Increased mRNA levels of RHAMM were observed in 29 specimens (97%), CD44s (all forms) in 21 specimens (70%), and its exon 6 in 19 specimens (63%) in comparison with those in the corresponding noncancerous tissue specimens. A statistically significant correlation between RHAMM expression and cancerous specimens at any of Dukes' stages A, B, and C was found, and the overexpression of CD44 mRNAs was confirmed in specimens at Dukes' stage C. Thus, our present study for the first time suggests that RHAMM expression may be a clinically useful indicator of colon cancer.

Keywords: RHAMM, CD44, Colon cancer, Real‐time RT‐PCR, Hyaluronan

Full Text

The Full Text of this article is available as a PDF (71.6 KB).

REFERENCES

  • 1).Toole , B. P. “ Cell Biology of the Extracellular Matrix, ” ed. Hey E. D. , pp . 259 – 294 ( 1980. ). Plenum Publishing Corp. , New York . [Google Scholar]
  • 2).Weigel , P. H. , Hascall , V. C. H. and Tammi , M.Hyaluronan synthases . J. Biol. Chem. , 272 , 13997 – 14000 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 3).Kimata , K. , Honma , Y. , Okayama , M. , Oguri , K. , Hozumi , M. and Suzuki , S.Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential . Cancer Res. , 43 , 1347 – 1354 ( 1983. ). [PubMed] [Google Scholar]
  • 4).Lesley , J. , Hyman , R. and Kincade , P. W.CD44 and its interaction with the cellular matrix . Adv. Immunol. , 54 , 271 – 335 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 5).Sherman , L. , Sleeman , J. , Herrlich , P. and Ponta , H.Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression . Curr. Opin. Cell Biol. , 6 , 726 – 733 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 6).Guo , Y. , Ma , J. , Wang , J. , Che , X. , Narula , J. , Bigby , M. , Wu , M. and Sy , M.‐S.Inhibition of human melanoma growth and metastasis in vivo by anti‐CD44 monoclonal antibody . Cancer Res. , 54 , 1561 – 1565 ( 1994. ). [PubMed] [Google Scholar]
  • 7).Matsumura , Y. and Tarin , D.Significance of CD44 gene products for cancer diagnosis and disease evaluation . Lancet , 340 , 1053 – 1058 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 8).Goodison , S. , Yoshida , K. , Sugino , T. , Woodman , A. , Gorham , H. , Bolodeoku , J. , Kaufmann , M. and Tarin , D.Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors . Cancer Res. , 57 , 3140 – 3144 ( 1997. ). [PubMed] [Google Scholar]
  • 9).Reeder , J. A. , Gotley , D. C. , Walsh , M. D. , Fawcett , J. and Antalis , T. M.Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment . Cancer Res. , 58 , 3719 – 3726 ( 1998. ). [PubMed] [Google Scholar]
  • 10).Matsumura , Y. , Hanbury , D. , Smith , J. and Tarin , J.Non‐invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells . Br. Med. J. , 308 , 619 – 624 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11).Turley , E. A. , Austen , L. , Vandeligt , K. and Clary , C.Hyaluronan and a cell‐associated hyaluronan binding protein regulate the locomotion of ras‐transformed cells . J. Cell Biol. , 112 , 1041 – 1047 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12).Hall , C. L. , Yang , B. , Yang , X. , Zahng , S. , Turley , M. , Samuel , S. , Lange , L. A. , Wang , C. , Curpen , G. D. , Savani , R. C. , Greenberg , A. H. and Turley , E. A.Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H‐ras transformation . Cell , 82 , 19 – 28 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 13).Wang , C. , Thor , A. D. , Moore , D. H. , II , Zhao , Y. , Kerschmann , R. , Stern , R. , Watson , P. H. and Turley , E. A.The overexpression of RHAMM, a hyaluronan‐binding protein that regulates ras signaling, correlates with over expression of mitogen‐activated protein kinase and is a significant parameter in breast cancer progression . Clin. Cancer Res. , 4 , 567 – 576 ( 1998. ). [PubMed] [Google Scholar]
  • 14).Turley , E. A. and Tretiak , M.Glycosaminoglycan production by murine melanoma variants in vivo and in vitro . Cancer Res. , 45 , 5098 – 5105 ( 1985. ). [PubMed] [Google Scholar]
  • 15).Zhang , L. , Underhill , C. B. and Chen , L.Hyaluronan on the surface of tumor cells is correlated with metastatic behavior . Cancer Res. , 55 , 428 – 433 ( 1995. ). [PubMed] [Google Scholar]
  • 16).Itano , N. , Sawai , T. , Miyaishi , O. and Kimata , K.Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells . Cancer Res. , 59 , 2499 – 2504 ( 1999. ). [PubMed] [Google Scholar]
  • 17).Heid , C.A. , Stevens , J. and Williams , P. M.Real time quantitative PCR . Genome Res. , 6 , 986 – 994 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 18).Gibson , U. E. M. , Heid , C. A. and Williams , A.Novel method for real time quantitative RT‐PCR . Genome Res. , 6 , 995 – 1001 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 19).Abetamann , V. , Kern , H. F. and Elsasser , H. P.Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells . Clin. Cancer Res. , 2 , 1607 – 1618 ( 1996. ). [PubMed] [Google Scholar]
  • 20).Teder , P. , Bergh , J. and Heldin , P.Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines . Cancer Res. , 55 , 3908 – 3914 ( 1995. ). [PubMed] [Google Scholar]
  • 21).Hofmann , M. , Rudy , W. , Zoller , M. , Tolg , C. , Ponta , H. , Herrlich , P. and Gunthert , U.CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines . Cancer Res. , 51 , 5292 – 5297 ( 1991. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES